ArticleScientific reports2023

Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidase.

Faeze Yousefnejad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.